oral tirzepatide vs injectable semaglutide tirzepatide Day 1: Injectables vs. Orals – Which Weight Loss Medication is Right When it comes to the

GLP-1 medications carry a boxed warning in the United States for the risk of thyroid C-cell tumors, based on rodent studies in which prolonged GLP-1 receptor stimulation led to tumor formation

It also will not impact Cigna workers whose drugs are covered to treat type 2 diabetes

Available online at: 209

Potential claims generally involve medications containing the active ingredient semaglutide or tirzepatide, including Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound

A., Kittelsrud, J., et al

The following category of individuals should avoid taking semaglutide for weight loss: Anyone with a history of pancreatitis Pregnant or breastfeeding women Those taking insulin or other blood sugar medications Individuals with kidney or gallbladder issues People with a history of medullary thyroid cancer (MTC) Anyone who has been diagnosed with depression Those diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Individuals planning to undergo surgery People with known allergies to semaglutide Side Effects of Using Semaglutide for Weight Loss Medicines surely can cause side effects, but it is not necessary that everyone experiences them